Published in J Pharmacol Exp Ther on November 01, 1998
Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci (2009) 2.35
The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol (2008) 1.49
Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) (2004) 1.22
Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A (2006) 1.22
Structural basis for inhibition of histamine N-methyltransferase by diverse drugs. J Mol Biol (2005) 1.18
Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons. Structure (2001) 1.17
The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol (2011) 1.13
Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain. Br J Pharmacol (2000) 1.12
Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology (2010) 1.10
Histamine in the regulation of wakefulness. Sleep Med Rev (2010) 1.05
Protean agonism at histamine H3 receptors in vitro and in vivo. Proc Natl Acad Sci U S A (2003) 1.04
Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol (2004) 1.03
CNTRICS final animal model task selection: control of attention. Neurosci Biobehav Rev (2012) 1.02
Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. Br J Pharmacol (2002) 0.94
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev (2015) 0.88
Attention-modulating effects of cognitive enhancers. Pharmacol Biochem Behav (2011) 0.88
Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice. Br J Pharmacol (2009) 0.88
Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease. Neurobiol Learn Mem (2010) 0.87
The H3 antagonist, ciproxifan, alleviates the memory impairment but enhances the motor effects of MK-801 (dizocilpine) in rats. Neuropharmacology (2010) 0.87
Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists. Psychopharmacology (Berl) (2010) 0.86
In vivo demonstration of H3-histaminergic inhibition of cardiac sympathetic stimulation by R-alpha-methyl-histamine and its prodrug BP 2.94 in the dog. Br J Pharmacol (1999) 0.85
Drugs for sleep disorders: mechanisms and therapeutic prospects. Br J Clin Pharmacol (2006) 0.85
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040. Psychopharmacology (Berl) (2008) 0.84
Alzheimer's disease and age-related memory decline (preclinical). Pharmacol Biochem Behav (2011) 0.83
Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice. Neuropsychopharmacology (2013) 0.82
Effects of the H(3) antagonist, thioperamide, on behavioral alterations induced by systemic MK-801 administration in rats. Psychopharmacology (Berl) (2009) 0.81
H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization. Psychopharmacology (Berl) (2003) 0.80
H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval. Psychopharmacology (Berl) (2008) 0.78
Ligands for histamine H(3) receptors modulate cell proliferation and migration in rat oxyntic mucosa. Br J Pharmacol (2002) 0.78
Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task. Eur J Pharmacol (2007) 0.77
Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype. J Med Chem (2012) 0.77
Single dose of H3 receptor antagonist--ciproxifan--abolishes negative effects of chronic stress on cognitive processes in rats. Psychopharmacology (Berl) (2013) 0.77
Antihistaminic drugs modify casein-induced inflammation in the rat. Inflamm Res (2010) 0.77
The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. Psychopharmacology (Berl) (2006) 0.77
Predicting targets of compounds against neurological diseases using cheminformatic methodology. J Comput Aided Mol Des (2014) 0.76
Histamine H(3)-receptor antagonists inhibit gastroprotection by (R)-alpha-methylhistamine in the rat. Br J Pharmacol (2000) 0.76
Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor. PLoS One (2012) 0.76
The histaminergic system is involved in psychological stress-induced hyperthermia in rats. Physiol Rep (2017) 0.75
Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies. Front Neurosci (2016) 0.75
Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B. Sci Rep (2017) 0.75
Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats. Drug Des Devel Ther (2016) 0.75
The Effect of Subchronic Dosing of Ciproxifan and Clobenpropit on Dopamine and Histamine Levels in Rats. J Exp Neurosci (2015) 0.75
Sleep disturbances, psychiatric disorders, and psychotropic drugs. Dialogues Clin Neurosci (2005) 0.75
Ciproxifan, an H3 receptor antagonist, improves short-term recognition memory impaired by isoflurane anesthesia. J Anesth (2016) 0.75
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature (2001) 23.49
Definition and antagonism of histamine H 2 -receptors. Nature (1972) 18.58
Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect (2000) 9.30
Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect (2000) 8.37
Metiamide--an orally active histamine H2-receptor antagonist. Agents Actions (1973) 6.82
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science (1995) 6.28
Heart rate variability associated with particulate air pollution. Am Heart J (1999) 6.21
Ambient pollution and heart rate variability. Circulation (2000) 6.20
Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology (2001) 5.80
Daily mortality and PM10 pollution in Utah Valley. Arch Environ Health (1992) 5.71
The National Morbidity, Mortality, and Air Pollution Study. Part II: Morbidity and mortality from air pollution in the United States. Res Rep Health Eff Inst (2000) 5.64
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature (2000) 5.55
The nucleotide sequence of the cloned rpoD gene for the RNA polymerase sigma subunit from E coli K12. Nucleic Acids Res (1981) 5.52
The time course of weather-related deaths. Epidemiology (2001) 5.17
Air pollution and incidence of cardiac arrhythmia. Epidemiology (2000) 4.96
The contribution of lead-contaminated house dust and residential soil to children's blood lead levels. A pooled analysis of 12 epidemiologic studies. Environ Res (1998) 4.94
Single-particle electron cryo-microscopy: towards atomic resolution. Q Rev Biophys (2000) 4.86
Crystal structure of TFIID TATA-box binding protein. Nature (1992) 4.85
Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell (2001) 4.58
Air pollution and daily mortality: associations with particulates and acid aerosols. Environ Res (1992) 4.02
Obesity-related glomerulopathy: an emerging epidemic. Kidney Int (2001) 3.98
Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health (1996) 3.90
Airborne particles are a risk factor for hospital admissions for heart and lung disease. Environ Health Perspect (2000) 3.74
Generalized additive distributed lag models: quantifying mortality displacement. Biostatistics (2000) 3.52
Temperature, temperature extremes, and mortality: a study of acclimatisation and effect modification in 50 US cities. Occup Environ Med (2007) 3.48
An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem (2000) 3.44
Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med (2001) 3.40
Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology. Agents Actions (1977) 3.33
The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemiol (1985) 3.31
Short-term effects of particulate air pollution on cardiovascular diseases in eight European cities. J Epidemiol Community Health (2002) 3.29
Chemical differentiation of histamine H1- and H2-receptor agonists. J Med Chem (1975) 3.20
Short-term effects of ambient oxidant exposure on mortality: a combined analysis within the APHEA project. Air Pollution and Health: a European Approach. Am J Epidemiol (1997) 3.15
The role of the nucleus accumbens in instrumental conditioning: Evidence of a functional dissociation between accumbens core and shell. J Neurosci (2001) 3.15
Phenotypic diversity and ecosystem functioning in changing environments: a theoretical framework. Proc Natl Acad Sci U S A (2001) 3.13
Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am J Respir Crit Care Med (1994) 3.13
The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium. Mol Microbiol (1995) 3.11
Oxygen saturation, pulse rate, and particulate air pollution: A daily time-series panel study. Am J Respir Crit Care Med (1999) 3.10
Relation of body mass index to asthma and atopy in children: the National Health and Nutrition Examination Study III. Thorax (2001) 3.10
The National Morbidity, Mortality, and Air Pollution Study. Part I: Methods and methodologic issues. Res Rep Health Eff Inst (2000) 3.07
Some chemical aspects of histamine H2-receptor antagonists. Fed Proc (1976) 3.07
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Concerning the egress of herpes simplex virus from infected cells: electron and light microscope observations. Virology (1969) 2.99
Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J Cell Biol (1994) 2.95
Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors. Nature (1978) 2.91
Highly potent and selective ligands for histamine H3-receptors. Nature (1987) 2.90
Signal transduction by the TCR for antigen. Curr Opin Immunol (2000) 2.87
Air pollution and daily mortality in Erfurt, east Germany, 1980-1989. Environ Health Perspect (1993) 2.84
Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med (2006) 2.80
mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol (1996) 2.78
Both lumenal and cytosolic gating of the aqueous ER translocon pore are regulated from inside the ribosome during membrane protein integration. Cell (1997) 2.71
International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev (1997) 2.71
Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines. J Med Chem (1990) 2.70
Compounds affecting the central nervous system. I. 4-Piperidones and related compounds. J Med Chem (1965) 2.69
The dynamics of cocirculating influenza strains conferring partial cross-immunity. J Math Biol (1997) 2.69
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science (1995) 2.68
Time-series analysis of air pollution and cause-specific mortality. Epidemiology (1998) 2.60
Structural analysis of a set of proteins resulting from a bacterial genomics project. Proteins (2005) 2.59
Effects of exposure to air pollution on blood coagulation. J Thromb Haemost (2006) 2.52
Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene (1994) 2.47
Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res (1988) 2.46
Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation (2001) 2.46
Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Am J Respir Crit Care Med (1997) 2.45
Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med (1995) 2.44
Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project. Eur Respir J (1997) 2.43
Shotgun optical maps of the whole Escherichia coli O157:H7 genome. Genome Res (2001) 2.43
Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. Nature (1997) 2.41
Emotion knowledge: further exploration of a prototype approach. J Pers Soc Psychol (1987) 2.38
Is air pollution a risk factor for low birth weight in Seoul? Epidemiology (2001) 2.38
Biogenic amines and the states of sleep. Science (1969) 2.32
Urban air pollution and emergency admissions for asthma in four European cities: the APHEA Project. Thorax (1997) 2.31
The lag structure between particulate air pollution and respiratory and cardiovascular deaths in 10 US cities. J Occup Environ Med (2001) 2.31
Air pollution and respiratory symptoms in preschool children. Am Rev Respir Dis (1992) 2.28
Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol (1995) 2.25
Control for seasonal variation and time trend in case-crossover studies of acute effects of environmental exposures. Epidemiology (1999) 2.25
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene (2001) 2.25
Air pollution and mortality in elderly people: a time-series study in Sao Paulo, Brazil. Arch Environ Health (1995) 2.24
Association between psychosocial work characteristics and health functioning in American women: prospective study. BMJ (2000) 2.23
PartsList: a web-based system for dynamically ranking protein folds based on disparate attributes, including whole-genome expression and interaction information. Nucleic Acids Res (2001) 2.23
Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int (2006) 2.23
Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes (2001) 2.19
Are there sensitive subgroups for the effects of airborne particles? Environ Health Perspect (2000) 2.18
Expression and modulation of CD44 variant isoforms in humans. J Cell Biol (1994) 2.17
Patients with chronic obstructive pulmonary disease are at increased risk of death associated with urban particle air pollution: a case-crossover analysis. Am J Epidemiol (2000) 2.15
Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology (2006) 2.11
Relationship between childhood blood lead levels and stature. Pediatrics (1986) 2.10
Association of black carbon with cognition among children in a prospective birth cohort study. Am J Epidemiol (2007) 2.10
Completely diverted tube ileostomy compared with loop ileostomy for protection of low colorectal anastomosis: a pilot study. Colorectal Dis (2014) 2.06
rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1988) 2.06
Reconstruction of the ulnar collateral ligament in athletes. J Bone Joint Surg Am (1986) 2.05
Beyond synexpression relationships: local clustering of time-shifted and inverted gene expression profiles identifies new, biologically relevant interactions. J Mol Biol (2001) 2.03
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science (2000) 2.03
Evaluation of three hollow-fiber membrane oxygenators without integrated arterial filters for neonatal cardiopulmonary bypass. Perfusion (2011) 2.02
Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost (2007) 2.02
Ribose facilitates thallium-201 redistribution in patients with coronary artery disease. J Nucl Med (1991) 2.00
Short-term effects of nitrogen dioxide on mortality: an analysis within the APHEA project. Eur Respir J (2006) 2.00
Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol (2001) 1.97
The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol (1996) 1.97